55,317 Shares in Oscar Health, Inc. $OSCR Acquired by Los Angeles Capital Management LLC

Los Angeles Capital Management LLC bought a new stake in Oscar Health, Inc. (NYSE:OSCR) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm bought 55,317 shares of the company’s stock, valued at approximately $1,186,000.

Other institutional investors and hedge funds have also bought and sold shares of the company. Victory Capital Management Inc. boosted its position in shares of Oscar Health by 23.8% in the 1st quarter. Victory Capital Management Inc. now owns 285,997 shares of the company’s stock worth $3,749,000 after purchasing an additional 54,938 shares in the last quarter. Nuveen LLC acquired a new position in Oscar Health during the 1st quarter valued at about $29,684,000. NewEdge Advisors LLC raised its stake in Oscar Health by 89.7% in the first quarter. NewEdge Advisors LLC now owns 188,058 shares of the company’s stock valued at $2,465,000 after buying an additional 88,946 shares during the last quarter. Matauro LLC purchased a new stake in Oscar Health in the second quarter valued at about $1,508,000. Finally, Connor Clark & Lunn Investment Management Ltd. boosted its holdings in Oscar Health by 19.0% in the first quarter. Connor Clark & Lunn Investment Management Ltd. now owns 501,972 shares of the company’s stock worth $6,581,000 after acquiring an additional 79,979 shares in the last quarter. 75.70% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on OSCR shares. UBS Group upped their price objective on shares of Oscar Health from $11.00 to $12.00 and gave the company a “sell” rating in a report on Friday, November 7th. Wall Street Zen lowered shares of Oscar Health from a “hold” rating to a “sell” rating in a research note on Saturday, August 9th. The Goldman Sachs Group initiated coverage on shares of Oscar Health in a report on Tuesday, October 14th. They issued a “neutral” rating and a $17.00 price target for the company. Baird R W downgraded shares of Oscar Health from a “strong-buy” rating to a “hold” rating in a research note on Friday, July 25th. Finally, Barclays upped their target price on Oscar Health from $11.00 to $13.00 and gave the company an “underweight” rating in a research report on Monday. Six research analysts have rated the stock with a Hold rating and five have issued a Sell rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Reduce” and an average price target of $13.57.

Insider Buying and Selling

In other Oscar Health news, insider Mario Schlosser sold 395,000 shares of the company’s stock in a transaction on Monday, September 22nd. The shares were sold at an average price of $18.43, for a total value of $7,279,850.00. Following the sale, the insider directly owned 501,148 shares of the company’s stock, valued at approximately $9,236,157.64. This represents a 44.08% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 24.39% of the company’s stock.

Oscar Health Stock Performance

OSCR opened at $15.08 on Thursday. The company has a current ratio of 0.92, a quick ratio of 0.92 and a debt-to-equity ratio of 0.67. Oscar Health, Inc. has a 12-month low of $11.20 and a 12-month high of $23.80. The firm has a 50 day moving average of $19.04 and a two-hundred day moving average of $16.87. The firm has a market capitalization of $3.90 billion, a PE ratio of -13.46 and a beta of 1.88.

Oscar Health (NYSE:OSCR) last released its quarterly earnings data on Thursday, November 6th. The company reported ($0.53) EPS for the quarter, beating the consensus estimate of ($0.55) by $0.02. The business had revenue of $2.93 billion for the quarter, compared to the consensus estimate of $3.09 billion. Oscar Health had a negative net margin of 2.16% and a negative return on equity of 21.50%. The business’s revenue for the quarter was up 23.2% on a year-over-year basis. During the same period in the prior year, the firm earned ($0.22) EPS. Oscar Health has set its FY 2025 guidance at EPS. On average, analysts anticipate that Oscar Health, Inc. will post 0.69 EPS for the current year.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.